PROMOTE A HEALTHIER LIFE FOR HUMANKIND THROUGH ADVANCEMENTS IN SCIENCE.
BENEFIT THE PATIENTS WITH HIGH-QUALITY MEDICATION AS WE DETERMINED TO INNOVATE.
BUILD A LEADING GLOBAL BIOPHARMACEUTICAL GROUP TO SERVE MORE.
FULFILL SOCIAL RESPONSIBILITIES THROUGH ACCOUNTABLE ACTIONS.
新闻速?/p>
2026 AAD︱AGGAME医药全球首创IL-23p19/IL-36R双靶点抗体SHR-1139用于中重度斑块状银屑病患者I期研究数据重磅公?/p>
焦点新闻
AGGAME医药披露Myosin抑制剂HRS-1893治疗梗阻性肥厚型心肌病II期研究积极结?/p>
公益新闻
AGGAME医药捐赠1000万港?,驰援香港大埔火灾救?/p>
创立?/p>
全球员工
1类创新药
2类新?/p>
SH 600276
HK 1276
关于我们
投资者关?/p>
人才发展,了解更?/p>